Evicenter
MarkdownMedical informationP&T meetings
Onvuzosiran (ADX-324)

Prophylaxis of hereditary angioedema attacks

Launch
Not announced
Last updated
119 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology

Prevalence of hereditary angioedema

7 evidence topics · 5 sources

Pooled diagnosed annual prevalence: combined HAE types and 95% confidence interval